We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
A biomarker analysis in luminal breast cancer using a humanized tumor mouse (HTM) model has been published in International Journal of Cancer.
We are delighted to inform you that an overview of data on CDK4/6 inhibitors in the treatment of breast cancer has been published in Breast.
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.